Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZambeef Prod. Regulatory News (ZAM)

Share Price Information for Zambeef Prod. (ZAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.75
ZAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

19 Jul 2013 07:00

RNS Number : 6986J
Zambeef Products PLC
19 July 2013
 



For Immediate release 19 July 2013

 

ZAMBEEF PRODUCTS PLC

("Zambeef" or the "Company")

 

Operational Update

Zambeef, the fully integrated agri-business with operations in Zambia, Nigeria and Ghana, updates the market on two current operational issues.

 

Food security

Zambeef notes reports in some Zambian newspapers that certain of its imported beef products ("Imported Beef Products") contained aromatic aldehydes or formaldehyde. Whilst aromatic aldehydes and formaldehyde are found naturally in most food products, excessive levels can be harmful to humans. Accordingly, on learning of these reports, the board of directors of Zambeef (the "Board"), in conjunction with the Ministry of Health, immediately removed all Imported Beef Products from Zambeef's retail outlets as a precautionary measure and no Imported Beef Products are now being offered for sale by the Company. In addition, the Company has cooperated fully with the Ministry of Health and other regulatory authorities to bring a swift conclusion to this matter.

 

Following receipt of tests commissioned by the government, the Minister of Health, the Hon. Dr Joseph Kasonde, MP (the "Minister"), yesterday stated that the tests indicated the presence of formaldehyde in samples of Zambeef's Imported Beef Products and that the Ministry of Health is working on establishing the point of contamination. 

As yet, these results have not been made available to the Company, therefore Zambeef's internal food safety specialists have not had an opportunity to review the results.

 

The Board takes food safety issues extremely seriously and Zambeef will never knowingly offer for sale any products which could be hazardous to the health of its customers. As a consequence, the Company will be undertaking a comprehensive review of internal food transport, handling and storage procedures as well as conducting extensive investigative dialogue with officials from the importing countries. It will also continue to cooperate with the government and relevant authorities to identify the level and potential source of any contamination.

 

The Company has made clear to consumers, via local media sources, that Zambeef only imports meat products from internationally recognised meat companies in countries with globally recognised traceability protocols in place, namely the United Kingdom, Republic of Ireland or the United States of America and that its Imported Beef Products are accompanied by certification from all of the required regulatory authorities in these countries, as applicable. The embargo on Imported Beef Products remains in place until further notice.

 

The sale of Imported Beef Products accounted for approx. four per cent. of the Company's annual turnover in 2012. Nevertheless the Company recognises that the negative publicity created by this matter could impact other product lines and, in doing so, Zambeef's profitability for the current financial year. These effects are difficult to quantify in the short term, but the Board will provide a further update in its pre-close statement in late September.

 

Wheat prices

The Board notes that the global and Zambian wheat price is currently lower than had previously been forecast. The Company normally harvests circa 45,000 tonnes of wheat per annum, of which it retains circa 30,000 tonnes, which is used to supply its milling and bakery division, and typically sells the surplus into the open market. Whilst the Company has yet to enter into any fixed price sales contracts, it is considered likely that any such contracts will be at lower prices than had previously been forecast and that valuation of its year end stocks will be correspondingly lower.

 

The effect of the lower valuation placed on wheat stocks will, in all likelihood, reduce the Company's annual profitability below market consensus. A further update on the anticipated impact of this will be made in the pre-close statement expected to be published in late September.

 

Commenting, Francis Grogan, Zambeef's CEO, said, "Clearly it has been a difficult period in light of the reports concerning the Company's Imported Beef Products and we are cooperating fully with the government to draw a line under the matter. We are committed to ensuring all products sold by Zambeef are of the highest quality and safe for our consumers, which is why we will continue to suspend the sale of Imported Beef Products until the Ministry of Health and Zambeef have fully resolved the matter.

 

Zambeef is focused on building a well-diversified business model which helps us to mitigate the impact of volatility in commodity markets caused by the effect of variable climatic conditions on world agricultural production. Therefore, whilst the global wheat price will depress the valuation of our wheat stocks, we believe that Zambeef remains well placed to build on its position as one of the leading food producers in Sub-Saharan Africa."

 

**ENDS**

 

For further information, please contact:

 

Zambeef Products plc Tel: +260 (0) 211 369003

Francis Grogan, Chief Executive Officer

Yusuf Koya, Executive Director

 

Strand Hanson Limited Tel: +44 (0) 20 7409 3494

Angela Hallett

James Spinney

 

Panmure Gordon Tel: +44 (0) 20 7886 2500

Callum Stewart

Hannah Woodley

 

Buchanan Tel: +44 (0) 20 7466 5000

Mark Edwards

Sophie McNulty

www.buchanan.uk.com

 

Notes to Editors

 

Aromatic Aldehydes

Aromatic aldehydes are organic chemical compounds, many obtained from natural derivatives as well as commercial preparations. They are commonly used in the pharmaceutical, agriculture and plastics industries as well as in certain consumer applications, for example they are frequently used as fragrance agents in perfume. Aromatic aldehydes are also extensively used by the food industry as perfumes, flavouring agents and preservatives. The use of aldehydes in this way is completely safe and harmless for consumers, for instance, they occur naturally in vanilla beans, which are used in many deserts products, such as ice cream. Aromatic aldehydes are also used to synthesise other chemicals for use in agriculture and pharmaceuticals.

 

Aromatic aldehydes also have chemical components and properties that make them important in human biological functions. Carbohydrates, such as sugars and starches, are commonly found in the form of aromatic aldehydes, and are essential fuel for supply of energy to the human body.

 

Formaldehyde

As indicated by the World Health Organisation, formaldehyde occurs naturally in the environment as a metabolic intermediate and is present at low levels in most living organisms. Formaldehyde can be found naturally in food up to the levels of 300 to 400 mg/kg, including fruits and vegetables, meats (including beef), fish, crustacea and dried mushrooms. It is also employed in higher concentrations in non-food uses.

 

 

This publication is in line with standard practice for London Stock Exchange.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUGAMUPWUAB
Date   Source Headline
23rd Apr 20242:30 pmRNSTrading Update
9th Apr 20248:00 amRNSDirectorate Change
28th Mar 20247:00 amRNSNotice of Death of Chairman
3rd Jan 20249:30 amRNSResult of AGM
8th Dec 20238:00 amRNSPosting of Annual Report and Notice of AGM
7th Dec 20239:00 amRNSFull Year Results
4th Dec 20238:09 amRNSTrading Statement
7th Nov 20232:00 pmRNSFull Year Trading Update
18th Oct 20235:35 pmRNSHolding(s) in Company
21st Sep 202311:39 amRNSGroup Restructuring
30th Jun 20237:00 amRNSHalf-year Results
21st Jun 202310:00 amRNSDirectorate Change
9th Jun 20238:00 amRNSTrading Statement
7th Jun 20238:00 amRNSTrading Update
21st Apr 20231:00 pmRNSDirectorate Change
5th Dec 20223:00 pmRNSFull Year Results
1st Dec 202212:00 pmRNSDirectorate Change
30th Nov 20228:00 amRNSTrading Statement
22nd Nov 202210:00 amRNSDirectorate Change
10th Nov 20223:00 pmRNSTrading Update
18th Jul 20228:30 amRNSInternational Finance Corporation Funding
29th Jun 20221:30 pmRNSChange of Chief Executive Officer
27th Jun 20222:05 pmRNSSecond Price Monitoring Extn
27th Jun 20222:00 pmRNSPrice Monitoring Extension
16th Jun 20224:41 pmRNSSecond Price Monitoring Extn
16th Jun 20224:35 pmRNSPrice Monitoring Extension
16th Jun 20222:06 pmRNSSecond Price Monitoring Extn
16th Jun 20222:00 pmRNSPrice Monitoring Extension
16th Jun 202211:05 amRNSSecond Price Monitoring Extn
16th Jun 202211:00 amRNSPrice Monitoring Extension
16th Jun 20229:30 amRNSUSD100m Investment Strategy
15th Jun 20223:30 pmRNSInterim Results
31st May 20228:00 amRNSTrading Statement
30th May 202210:00 amRNSDirectorate Change
27th Apr 20221:00 pmRNSHalf Year Trading Update
14th Apr 20221:00 pmRNSDirectorate Change
22nd Mar 20222:28 pmRNSHolding(s) in Company
21st Dec 20212:00 pmRNSResult of AGM and Appointment of External Auditor
30th Nov 20219:00 amRNSFull Year Results
19th Nov 202112:37 pmRNSAMENDED: Trading Statement
18th Nov 20218:00 amRNSTrading Statement
21st Oct 20212:00 pmRNSYear End Trading Update
13th Jul 20219:09 amRNSHolding(s) in Company
29th Jun 20218:29 amRNSDirector/PDMR Shareholding
11th Jun 202111:30 amRNSHalf-year Report
4th Jun 20212:59 pmRNSHolding(s) in Company
3rd Jun 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSHalf Year Trading Update
10th Mar 202111:21 amRNSChange of Adviser and Directorate Changes
26th Feb 20217:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.